Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew M. Loar currently holds 300,000 shares of MATEON THERAPEUTICS INC (MATN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew M. Loar has been a net buyer of MATN stock. They have purchased $18.8K and sold $0 worth of shares.
Matthew M. Loar's most recent insider trade was on Apr 12, 2018, when they purchased 250,000 shares at $0.00 per share.
Matthew M. Loar serves as Executive at MATEON THERAPEUTICS INC (MATN). They have executed 2 insider transactions totaling $18.8K over their tenure at the company.
Matthew M. Loar holds the position of Executive at MATEON THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Matthew M. Loar has shown a buying trading pattern, with $18.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew M. Loar was on Oct 22, 2008, when they purchased $18.8K worth of NTII shares. This transaction involved 25,000 shares at $0.75 per share.
Matthew M. Loar currently owns 300,000 shares of MATEON THERAPEUTICS INC (MATN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew M. Loar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew M. Loar has 2 Form 4 filings on record as an insider at MATEON THERAPEUTICS INC.
Set alerts for Matthew M. Loar and 40,000+ other insiders.